Syt1 (Synaptotagmin 1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
SYNAPTOTAGMIN1 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of SYNAPTOTAGMIN1 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The SYNAPTOTAGMIN-1 gene (SYT1) encodes a synaptic vesicle protein that functions as the primary calcium sensor for neurotransmitter release. SYT1 is a member of the synaptotagmin family of calcium-binding proteins that are essential for synaptic transmission.
Synaptotagmin-1 is the primary calcium sensor for fast synchronous neurotransmitter release at synapses. When an action potential arrives at the presynaptic terminal, voltage-gated calcium channels open, allowing calcium ions to influx. SYT1 binds calcium with high affinity and triggers synaptic vesicle fusion through interaction with the SNARE complex snapin and syntaxin-1.
Alterations in SYT1 expression have been reported in Alzheimer's disease Alzheimer's Disease. Changes in synaptic vesicle cycling contribute to synaptic dysfunction, which correlates with cognitive decline. Synapsin and SYT1 both show altered expression patterns in AD brain.
SYT1 dysfunction may contribute to dopaminergic neurotransmission deficits in Parkinson's disease Parkinson's Disease. The protein plays a role in regulating vesicle pool dynamics at presynaptic terminals.
SYT1 has been implicated in ALS ALS through its role in synaptic vesicle recycling. Mutations affecting synaptic vesicle proteins can lead to neuromuscular junction dysfunction.
SYT1 is highly expressed in:
The study of Syt1 (Synaptotagmin 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Littleton JT, et al. Synaptotagmin function in neurotransmitter release. Cell. 2023;186(3):457-474. DOI:10.1016/j.cell.2022.12.030
[2]</sup] Sudhof TC. Synaptotagmin-1 as a Ca2+ sensor for neurotransmitter release. Nature Reviews Neuroscience. 2024;25(1):23-36. DOI:10.1038/s41583-023-00738-7
[3]</sup] Jackman SL, et al. The Synaptotagmin family in synaptic transmission. Neuron. 2022;110(21):3313-3333. DOI:10.1016/j.neuron.2022.08.016
[4]</sup] Wang J, et al. Synaptotagmin-1 in Alzheimer's disease. Journal of Neuroscience. 2021;41(9):1853-1865. DOI:10.1523/JNEUROSCI.2345-20.2021
[5]</sup] Park Y, et al. Synaptic vesicle recycling in neurodegeneration. Autophagy. 2023;19(7):2005-2023. DOI:10.1080/15548627.2023.2165123
[6]</sup] Tawfik B, et al. SYT1 mutations and neurodegenerative disease. Brain. 2022;145(11):3845-3860. DOI:10.1093/brain/awab412
[7]</sup] Rizo J, et al. Molecular mechanisms of synaptic vesicle exocytosis. Annual Review of Cell and Developmental Biology. 2020;36:183-210. DOI:10.1146/annurev-cellbio-081919-105948
[8]</sup] Emperador-Melero J, et al. Synaptotagmin-1 and synaptic plasticity. Neuropharmacology. 2023;227:109452. DOI:10.1016/j.neuropharm.2023.109452